LGALS3 and Hyperglycemia: Based on the underlying pathomechanisms of fibrosis and inflammation in hyperglycaemia-induced cardiac alteration, the biomarker galectin-3 may be a promising target in monitoring cardiac function especially in people with impaired glucose metabolism33, which was aimed to be investigated in the present study.